{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Rockford",
      "state": "IL",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82210",
      "recalling_firm": "Mylan Institutional Inc",
      "address_1": "4951 Hiawatha Dr",
      "address_2": "N/A",
      "postal_code": "61103-1287",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the United States",
      "recall_number": "D-1059-2019",
      "product_description": "Levoleucovorin Injection, 250 mg/25 mL, (10 mg/mL), 25 mL Single-Use Vial, Rx only, Manufactured for:  Mylan Institutional LLC, Rockford, IL 61103 U.S.A., Made in India.  NDC: 67457-601-30",
      "product_quantity": "11,964 cartons of 30 vials",
      "reason_for_recall": "Presence of Particulate Matter: particulate matter identified as copper salts",
      "recall_initiation_date": "20190201",
      "center_classification_date": "20190326",
      "termination_date": "20200619",
      "report_date": "20190320",
      "code_info": "Lot #: APB032, APB033, Exp. April 2019"
    }
  ]
}